HRTX logo
Heron Therapeutics, Inc.(HRTX)
Last print unknown agoAbout this dataData status
$0.36▼-0.00 (-0.03%)Stale · unknown oldEarnings · Nov 3

HRTX R&D to Revenue

8.02%Fiscal year

Period ending:

HRTX FY R&D/Revenue%
HRTX FY R&D/Revenue9030.49%-967.55%
1987-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

HRTX r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 39 observations from Dec 31, 1987 to Dec 31, 2025.

Heron Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
8.0237%
11.5625%
30.8027%
76.8111%
151.5079%
196.9054%
114.6703%
180.7471%
450.4242%
8,062.9398%
0%
0%
0%
2,328.9474%
1,270.4334%
558.3397%
618.2395%
5,286.4499%
4,700%
282.6192%
191.0406%
212.7128%
178.6304%
115.2021%
167.4949%
110.309%
21.0784%
22%
21.5116%
18.7166%
25.4658%
39.6226%
0%
0%
0%
0%
0%
0%
0%

Compare r&d to revenue

All HRTX financial metrics · HRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.